Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
3
×
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
3
×
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
bayer
biogen
bristol-myers squibb
cancer
car-t immunotherapy
clinical trials
diagnostics
What
bio
drug
roundup
companies
nash
news
acquisitions
albert
approval
approved
biggest
biogen’s
biopharmaceutical
bourla
ceo
company
convo
crispr
digital
disease
earlier
epidemic
failures
fatty
fda
frenzied
future
growing
imports
known
led
littered
liver
maker
maps
measured
merck
new
patients
pfizer
Language
unknown
Current search:
abbvie
×
merck
×
" san francisco blog main "
×
" cancer immunotherapy "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More